183 related articles for article (PubMed ID: 38674302)
41. Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer.
Yu S; Mamtani R; O'Hara MH; O'Dwyer PJ; Margalit O; Giantonio BJ; Shmueli E; Reiss KA; Boursi B
Clin Colorectal Cancer; 2021 Jun; 20(2):121-129. PubMed ID: 33608161
[TBL] [Abstract][Full Text] [Related]
42. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
[TBL] [Abstract][Full Text] [Related]
43. Total neoadjuvant therapy for locally advanced rectal cancer: a three-group propensity score matched study.
Zhou J; Huang J; Zhou Z; Deng X; Wu Q; Wang Z
Int J Colorectal Dis; 2024 Mar; 39(1):38. PubMed ID: 38492080
[TBL] [Abstract][Full Text] [Related]
44. Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
Voogt ELK; Schaap DP; van den Berg K; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Willems J; Cnossen JS; Peulen HMU; Nederend J; van Lijnschoten G; Burger JWA; Rutten HJT
Eur J Surg Oncol; 2021 Sep; 47(9):2429-2435. PubMed ID: 34030921
[TBL] [Abstract][Full Text] [Related]
45. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
[TBL] [Abstract][Full Text] [Related]
46. Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer: A Comparison of Short- and Long-term Oncologic Outcomes.
Goffredo P; Khan A; Mott SL; Jensen CC; Madoff RD; Gaertner WB; You YN; Hassan I
Ann Surg; 2022 Dec; 276(6):e819-e824. PubMed ID: 34353995
[TBL] [Abstract][Full Text] [Related]
47. MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
Kim H; Myoung S; Koom WS; Kim NK; Kim MJ; Ahn JB; Hur H; Lim JS
PLoS One; 2016; 11(1):e0146235. PubMed ID: 26730717
[TBL] [Abstract][Full Text] [Related]
48. Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review.
Mori R; Uemura M; Sekido Y; Hata T; Ogino T; Takahashi H; Miyoshi N; Mizushima T; Doki Y; Eguchi H
World J Surg Oncol; 2022 May; 20(1):166. PubMed ID: 35619103
[TBL] [Abstract][Full Text] [Related]
49. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.
Sloothaak DA; Geijsen DE; van Leersum NJ; Punt CJ; Buskens CJ; Bemelman WA; Tanis PJ;
Br J Surg; 2013 Jun; 100(7):933-9. PubMed ID: 23536485
[TBL] [Abstract][Full Text] [Related]
50. Local recurrence after five years is associated with preoperative chemoradiotherapy treatment in patients diagnosed with stage II and III rectal cancer.
Marin G; Suárez J; Vera R; Balén E; Viudez A; Mata E
Int J Surg; 2017 Aug; 44():15-20. PubMed ID: 28583894
[TBL] [Abstract][Full Text] [Related]
51. Effects of neoadjuvant chemotherapy plus chemoradiotherapy on lymph nodes in rectal adenocarcinoma.
Chotard G; Capdepont M; Denost Q; Smith D; Vendrely V; Rullier E; Rullier A
Virchows Arch; 2021 Oct; 479(4):657-666. PubMed ID: 33983519
[TBL] [Abstract][Full Text] [Related]
52. Compliance and Toxicity of Total Neoadjuvant Therapy for Rectal Cancer: A Secondary Analysis of the OPRA Trial.
Verheij FS; Omer DM; Lin ST; Yuval JB; Thompson HM; Kim JK; Valdivieso SC; Qin LX; Wu AJ; Saltz LB; Garcia-Aguilar J
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):115-123. PubMed ID: 37544412
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
54. Predictive role of diffusion-weighted MRI in the assessment of response to total neoadjuvant therapy in locally advanced rectal cancer.
Iafrate F; Ciccarelli F; Masci GM; Grasso D; Marruzzo F; De Felice F; Tombolini V; D'Ambrosio G; Magliocca FM; Cortesi E; Catalano C
Eur Radiol; 2023 Feb; 33(2):854-862. PubMed ID: 35980431
[TBL] [Abstract][Full Text] [Related]
55. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer.
Caudle AS; Kim HJ; Tepper JE; O'Neil BH; Lange LA; Goldberg RM; Bernard SA; Calvo BF; Meyers MO
Ann Surg Oncol; 2008 Jul; 15(7):1931-6. PubMed ID: 18418656
[TBL] [Abstract][Full Text] [Related]
56. Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data.
Verrijssen AS; Guillem J; Perez R; Bujko K; Guedj N; Habr-Gama A; Houben R; Goudkade D; Melenhorst J; Buijsen J; Vanneste B; Grabsch HI; Bellezzo M; Paiva Fonseca G; Verhaegen F; Berbee M; Van Limbergen EJ
Radiother Oncol; 2020 Mar; 144():37-45. PubMed ID: 31710942
[TBL] [Abstract][Full Text] [Related]
57. Neoadjuvant-intensified treatment for rectal cancer: time to change?
Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
[TBL] [Abstract][Full Text] [Related]
58. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
59. Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.
Petrelli F; Trevisan F; Cabiddu M; Sgroi G; Bruschieri L; Rausa E; Ghidini M; Turati L
Ann Surg; 2020 Mar; 271(3):440-448. PubMed ID: 31318794
[TBL] [Abstract][Full Text] [Related]
60. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer.
Ren DL; Li J; Yu HC; Peng SY; Lin WD; Wang XL; Ghoorun RA; Luo YX
World J Gastroenterol; 2019 Jan; 25(1):118-137. PubMed ID: 30643363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]